SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?


To: Tulvio Durand who wrote (877)6/22/1998 3:06:00 PM
From: FrLR  Respond to of 1055
 
The CFO reportedly commented on EPS - he indicated that THRX was comfortable with 9c-11c analyst estimates.

Someone mentioned that an insider sold 43,000 shares taking his pos
to zero.

On Saturday Clinton mentioned more funding being provided for prostate cancer research.

Also the maker of THRX's cyclotrons came public.

These are the only pieces of new info I have been able to find(check yahoo's message board) None of these pieces of info truely explain
the drop IMHO. I did see that at about 1:35pm EST 250,000 shares crossed at 25. And up until 1pm the stock was above 27. So I believe
that some institution sold a large chunk of stock and the buyers got out of the way. I bought it at 23.125, 22.75 & 23.0625 which I believe
will soon prove to be very good purchase prices.



To: Tulvio Durand who wrote (877)6/22/1998 3:40:00 PM
From: FrLR  Read Replies (1) | Respond to of 1055
 
I talked to a trader that said that Dain Bosworth was "rumored" to have downgraded THRX. Can anyone confirm or refute this?